SCHEMBL6345921

SCHEMBL6345921

O=C1CSc2ccccc2NC1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MEN1 O00255 5/20 0.43
▸ GAA P10253 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ MAPT P10636 4/20 0.43
▸ MAOA P21397 4/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ BCHE P06276 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ CNR1 P21554 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13323 0.80 ALDH1A1 (0.60) ALDH1A1MEN1GAAKMT2AMAPT
Hydrochloric Acid SCHEMBL30648399 0.78 ALDH1A1 (0.58) ALDH1A1MEN1GAAKMT2AMAPT
SCHEMBL4811332 0.72 ALDH1A1 (0.60) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL19497757 0.72 ALDH1A1 (0.60) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL88687 0.72 ALDH1A1 (1.00) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL12463182 0.69 L3MBTL1 (0.66) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL12462878 0.69 L3MBTL1 (0.66) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL10337207 0.69 ALDH1A1 (0.47) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL7427944 0.69 ALDH1A1 (0.48) ALDH1A1L3MBTL1MEN1GAAKMT2A
SCHEMBL1756087 0.69 HDAC1 (0.51) ALDH1A1L3MBTL1MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6875877-B2 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides LI JINGLIN JAMES T (US) 2005-04-05 — — US disclosed
EP-1331225-A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides G.D. SEARLE & CO. (US) 2003-07-30 — — EP disclosed
EP-1042314-B1 METHOD OF PREPARING ENANTIOMERICALLY-ENRICHED TETRAHYDROBENZOTHIEPINE OXIDES SEARLE & CO (US) 2003-03-19 — — EP disclosed
US-20020188119-A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides LI JINGLIN (US) 2002-12-12 — — US disclosed
US-6369220-B1 OXIDIZING AN ARYL-3-HYDROXYPROPYLSULFIDE; OXIDIZING 3-HYDROXY GROUP INTO ARYL-3-PROPANALSULFOXIDE; CYCLIZATION G.D. SEARLE, LLC 2002-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188119-A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides TST, THOP1, TH ALDH1A1 767/4885L3MBTL1 3566/4885MEN1 3795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback